Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2

被引:0
|
作者
Rosanna Cardani
Marzia Giagnacovo
Annalisa Botta
Fabrizio Rinaldi
Alessandra Morgante
Bjarne Udd
Olayinka Raheem
Sini Penttilä
Tiina Suominen
Laura V. Renna
Valeria Sansone
Enrico Bugiardini
Giuseppe Novelli
Giovanni Meola
机构
[1] IRCCS Policlinico San Donato,Lab of Muscle Histopathology and Molecular Biology
[2] University of Milan,CMN
[3] University of Pavia,Neuromuscular Disease Center, IRCCS Policlinico San Donato
[4] Tor Vergata University of Rome,Department of Animal Biology
[5] University of Tampere,Department of Biopathology and Diagnosing Imaging
[6] University of Helsinki,Neuromuscular Research Unit
[7] University of Helsinki,Department of Medical Genetics, Haartman Institute
[8] Tampere University Hospital,Department of Medical Genetics, Folkhälsan Institute of Genetics
[9] Vaasa Central Hospital,Department of Neurology
[10] University of Milan,Department of Neurology
[11] San Peter Hospital,Department of Neurology, IRCCS Policlinico San Donato
[12] National Agency for the Evaluation of Universities and Research,undefined
[13] ANVUR,undefined
来源
Journal of Neurology | 2012年 / 259卷
关键词
Myotonic dystrophy type 2; Juvenile case; Muscle pathology; Myotonia congenita;
D O I
暂无
中图分类号
学科分类号
摘要
Myotonic dystrophy type 2 (DM2) is a common adult onset muscular dystrophy caused by a dominantly transmitted (CCTG)n expansion in intron 1 of the CNBP gene. In DM2 there is no obvious evidence for an intergenerational increase of expansion size, and no congenital cases have been confirmed. We describe the clinical and histopathological features, and provide the genetic and molecular explanation for juvenile onset of myotonia in a 14-year-old female with DM2 and her affected mother presenting with a more severe phenotype despite a later onset of symptoms. Histological and immunohistochemical findings correlated with disease severity or age at onset in both patients. Southern blot on both muscle and blood samples revealed only a small increase in the CCTG repeat number through maternal transmission. Fluorescence in situ hybridization, in combination with MBNL1 immunofluorescence on muscle sections, showed the presence of mutant mRNA and MBNL1 in nuclear foci; the fluorescence intensity and its area appeared to be similar in the two patients. Splicing analysis of the INSR, CLCN1 and MBNL1 genes in muscle tissue demonstrates that the level of aberrant splicing isoforms was lower in the daughter than in the mother. However, in the CLCN1 gene, a heterozygous mutation c.501C>G p.F167L was present in the daughter’s DNA and found to be maternally inherited. Biomolecular findings did not explain the unusual young onset in the daughter. The co-segregation of DM2 with a recessive CLCN1 mutation provided the explanation for the unusual clinical findings.
引用
收藏
页码:2090 / 2099
页数:9
相关论文
共 50 条
  • [41] Slow progression of muscle impairment and spliceopathy despite worsening of muscle histopathology in myotonic dystrophy type 2 (DM2)
    Meola, G.
    Bugiardini, E.
    Renna, L. V.
    Botta, A.
    Rossi, G.
    Pizzamiglio, C.
    Cardani, R.
    JOURNAL OF NEUROLOGY, 2013, 260 : S43 - S43
  • [42] Correction of Clcn1 Mis-Splicing Reverses Muscle Fiber Type Transition in Mice with Myotonic Dystrophy
    Hu, Ningyan
    Wheeler, Thurman
    MOLECULAR THERAPY, 2021, 29 (04) : 22 - 23
  • [43] Myotonic Dystrophy Type-2 (DM2): Patient-Reported Highest-Impact Symptoms and Issues
    Heatwole, Chad
    Bode, Rita
    Johnson, Nicholas
    Quinn, Christine
    Martens, William
    Moxley, Richard
    Vickrey, Barbara
    Victorson, David
    NEUROLOGY, 2011, 76 (09) : A529 - A529
  • [44] Relationships Between Cognitive and Motor Endpoints in Myotonic Dystrophy Type 2 (DM2): Is the Brain Driving Motor Dysfunction?
    Olszewski, Carly
    Flashman, Laura
    Burgos-Aguilar, Carolina
    Rigdon, Joseph
    Nopoulos, Peggy
    Puwanant, Araya
    ANNALS OF NEUROLOGY, 2021, 90 : S209 - S209
  • [45] Alternative splicing alterations of Ca2+handling genes are associated with Ca2+signal dysregulation in myotonic dystrophy type 1 ( DM1) and type 2 ( DM2) myotubes
    Santoro, M.
    Piacentini, R.
    Masciullo, M.
    Bianchi, M. L. E.
    Modoni, A.
    Podda, M. V.
    Ricci, E.
    Silvestri, G.
    Grassi, C.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2014, 40 (04) : 464 - 476
  • [46] Co-occurrence of the Gene ZNF9 Mutations (Myotonic Dystrophy Type 2) and Gene CLCN1 (Myotonia Congenita) in One Family - a Case Report
    Parmova, O.
    Vohanka, S.
    Fajkusova, L.
    Stehlikova, K.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 (05) : 648 - 651
  • [47] Gene expression analysis in myotonic dystrophy: Indications for a common molecular pathogenic pathway in DM1 and DM2
    Botta, Annalisa
    Vallo, Laura
    Rinaldi, Fabrizio
    Bonifazi, Emanuela
    Amati, Francesca
    Biancolella, Michela
    Gambardella, Stefano
    Mancinelli, Enzo
    Angelini, Corrado
    Meola, Giovanni
    Novelli, Giuseppe
    GENE EXPRESSION, 2007, 13 (06): : 339 - 351
  • [48] The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles
    Massa, R.
    Panico, M. B.
    Caldarola, S.
    Fusco, F. R.
    Sabatelli, P.
    Terracciano, C.
    Botta, A.
    Novelli, G.
    Bernardi, G.
    Loreni, F.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (04) : 275 - 284
  • [49] Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients
    Santoro, Massimo
    Fontana, Luana
    Maiorca, Francesca
    Centofanti, Federica
    Massa, Roberto
    Silvestri, Gabriella
    Novelli, Giuseppe
    Botta, Annalisa
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (03): : 917 - 924
  • [50] Altered Pre-mRNA Processing Is a Common Feature of Muscle Cells in Senescence and Myotonic Dystrophy Type 2 (DM2)
    Meola, Giovanni
    Malatesta, Manuela
    Perdoni, Federico
    Cardani, Rosanna
    Bugiardini, Enrico
    Giagnacovo, Marzia
    Pellicciari, Carlo
    NEUROLOGY, 2010, 74 (09) : A438 - A439